![美股盘前:Chewy飙升19% 特斯拉升1.9% 中国电动汽车股普升](https://i-invdn-com.investing.com/news/moved_small-LYNXMPEJ5K0JR_L.jpg)
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Pulmatrix Inc是一家临床阶段生物技术公司。该公司专注于发现和开发吸入治疗产品,以预防和治疗呼吸系统疾病和其他医疗需求未得到满足的疾病。该公司基于其干粉输送技术设计和开发吸入治疗产品,即易吸入和排放的吸入小颗粒(iSPERSE),该技术能够通过吸入将小分子或大分子药物输送至肺部,用于局部或全身应用。iSPERSE粉末是一种小而致密的颗粒,具有分散性并可输送至气道。iSPERSE的领先开发项目,Pulmazole是伊曲康唑的吸入制剂,伊曲康唑是一种口服抗真菌药物,目前正在开发用于治疗和预防肺部真菌感染。PUR1800正在开发用于治疗慢性阻塞性肺病急性加重,PUR3100正在开发用于治疗急性偏头痛。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Michael J. Higgins | 62 | 2015 | Independent Chairman |
Teofilo David Raad | 54 | 2017 | President, CEO & Director |
Richard B. Moss | - | - | Member of Pulmazole Clinical Advisory Board |
Christopher H. Cabell | 54 | 2020 | Independent Director |
Stewart J. Tepper | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Peter Wark | - | - | Member of Pulmazole Clinical Advisory Board |
Fernando Martinez | - | 2022 | Member of PUR1800 Clinical Advisory Board |
Cendrine Godet | - | - | Member of Pulmazole Clinical Advisory Board |
Jonathan Corren | - | - | Member of Pulmazole Clinical Advisory Board |
David A. Stevens | - | - | Member of Pulmazole Clinical Advisory Board |
David W. Denning | - | - | Member of Pulmazole Clinical Advisory Board |
William J. Calhoun | - | - | Chair of PUR1900 & PUR1800 Clinical Advisory Board |
Russell A. Settipane | - | - | Member of Pulmazole Clinical Advisory Board |
Ritesh Agarwal | - | - | Member of Pulmazole Clinical Advisory Board |
Peter J. Goadsby | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Abraham J. Nagy | - | - | Member of PUR3100 (DHE) Clinical Advisory Board |
Wisla Wedzicha | - | - | Member of PUR1800 Clinical Advisory Board |
Richard P. Batycky | 56 | 2019 | Independent Director |
Todd Bazemore | 54 | 2020 | Independent Director |
Russell G. Clayton | 63 | - | Member of Pulmazole & PUR1800 Clinical Advisory Board |
Michael E. Wechsler | - | - | Member of Pulmazole Clinical Advisory Board |
Mario Castro | - | - | Member of Pulmazole Clinical Advisory Board |
Anand Varadan | 57 | 2021 | Independent Director |
Stephen Silberstein | - | - | Chair of PUR3100 (DHE) Clinical Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核